Abstract:OBJECTIVE:To further study the impact of interferon-alpha (IFN-alpha) on thymidine phosphorylase (TP) expression and angiogenesis. METHODS:Human hepatocellular carcinoma cells of the line SMMC-7721 were cultured and added with IFN-alpha of different doses: 0 (as control group), 1000, 5000 and 10,000 U/ml. Twenty-four hours later RT-PCR was used to detect the TP mRNA expression. Boyden chamber method was used to examine the endothelial cells migration. Suspension of SMMC-7721 cells was inoculated subcutaneously into 30 male BALB/c-nu/nu mice, the mice were randomly divided into 5 equal groups to be subcutaneously injected with IFN-alpha of different doses: 0 (as control group), 1.0 x 10(6), 3.0 x 10(6), 9.0 x 10(6), and 1.5 x 10(7) U.kg(-1).d(-1) for 3 weeks. The eating behavior, activity, body weight, and tumor size were observed. The rats were killed 2 days after the drug injection was stopped. The subcutaneous tumors were taken out to undergo histological examination and TP protein expression by ELISA. The microvessel density (MVD) was detected using anti-CD34 monoclonal antibody. RESULTS:The TP mRNA expression of the SMMC-7721 cells induced by IFN-alpha of the doses of 5000 U/ml and 10,000 U/ml significantly increased in comparison with the un-treated SMMC-7721 cells (0 U/ml, P < 0.05). The endothelial cell migration significantly increased in the IFN-alpha 1000 U/ml group compared with the control group (P < 0.001), and then decreased along with the increase of IFN-alpha dose; there were no significant differences in the epithelial migration among the groups of 0, 5000, and 10,000 U/ml IFN-alpha doses (all P > 0.05). The TP protein expression levels of the tumor in the rats treated with IFN-alpha of the doses of 9.0 x 10(6), and 1.5 x 10(7) U.kg(-1).d(-1) were 48 ng/mg +/- 24 ng/mg and 60 ng/mg +/- 6 ng/mg respectively, 1.9 and 2.4 times that of the control group (both P < 0.01). The MVD of the tumors was 6.0 +/- 1.8 in the 9.0 x 10(6) U.kg(-1).d(-1) IFN-alpha group, significantly higher than that of the control group (P < 0.01); and was 4.0 +/- 1.5 in the 1.5 x 10(7) U.kg(-1).d(-1) group, significantly lower than that of the 9.0 x 10(6) U.kg(-1).d(-1) group (P < 0.05) and not significantly different from that of the control group. The tumor inhibiting rate of the 1.5 x 10(7) U.kg(-1).d(-1) IFN-alpha group was 68%, significantly higher than that of the untreated group (P < 0.05). CONCLUSION:IFN-alpha of certain doses up-regulate the TP expression, and inhibit the angiogenesis induced by TP as well.

Interferon-alpha 2a Up-Regulated Thymidine Phosphorylase and Enhanced Antitumor Effect of Capecitabine on Hepatocellular Carcinoma in Nude Mice

The Synergistic Antitumor Effect of IL-6 Neutralization with NVP-BEZ235 in Hepatocellular Carcinoma

Peginterferon-α combined with capecitabine inhibits tumor growth in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

[Up-Regulation of Thymidine Phosphorylase and Anti-Angiogenesis by Interferon Alpha in Human Hepatocellular Carcinoma Cell Line and Xenograft].

Interferon-α Combined with Herbal Compound "songyou Yin" Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model.

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Enhanced Efficacy of Direct Immunochemotherapy for Hepatic Cancer with Image-Guided Intratumoral Radiofrequency Hyperthermia

Mechanism of Interferon Alpha on Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma after Curative Resection in Nude Mice

High-Dose and Long-Term Therapy with Interferon-Alfa Inhibits Tumor Growth and Recurrence in Nude Mice Bearing Human Hepatocellular Carcinoma Xenografts with High Metastatic Potential

Capecitabine Inhibits Postoperative Recurrence and Metastasis after Liver Cancer Resection in Nude Mice with Relation to the Expression of Platelet-Derived Endothelial Cell Growth Factor

Intratumoral Radiofrequency Hyperthermia-Enhanced Chemotherapy of Liposomal Doxorubicin on Hepatocellular Carcinoma.

Long-Term Interferon-Alpha Treatment Suppresses Tumor Growth But Promotes Metastasis Capacity In Hepatocellular Carcinoma

Long-term Interferon-Α Treatment Suppresses Tumor Growth but Promotes Metastasis Capacity in Hepatocellular Carcinoma.

[Interferon Alpha Enhances the Sensitivity of SMMC-7721 Hepatocellular Carcinoma Cells to 5'-Deoxy-5-fluorouridine Related to Up-Regulation of Thymidine Phosphorylase].

Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma

A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma

DCA Increases the Antitumor Effects of Capecitabine in a Mouse B16 Melanoma Allograft and a Human Non-Small Cell Lung Cancer A549 Xenograft.

Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.

Interferon-α Significantly Inhibits the Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Expression in the Hepatocellular Carcinoma of Nude Mice Model with Highly Metastatic Potential

IFN-α Facilitates the Effect of Sorafenib Via Shifting the M2-like Polarization of TAM in Hepatocellular Carcinoma.

Experimental Research on Inhibition of Interferon-Alfa on Hepatocellular Carcinoma Reinforced by Chinese Herbal Compound Songyou Yin.